Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 27, 2026
Welltower (WELL) Q2 Earnings Preview: High Bar Set for Healthcare REIT Growth

Welltower (WELL) Q2 Earnings Preview: High Bar Set for Healthcare REIT Growth

Key Takeaways

  • Welltower is scheduled to report second-quarter 2026 results after the market closes on Monday, July 27, with a conference call set for Tuesday, July 28, at 9:00 a.m. ET.
  • Wall Street analysts expect normalized FFO (funds from operations — a key profitability metric for REITs that adds back depreciation and amortization to net income) of $1.55 per share, reflecting a 21.1% year-over-year increase.
  • Consensus revenue estimates stand at approximately $3.43 billion, which would represent a 34.5% jump from the same period last year.
  • The company enters this report with a four-quarter streak of beating FFO estimates, with an average surprise of roughly 2.5%.
  • Full-year 2026 normalized FFO guidance was raised to $6.21–$6.35 per share following the first quarter, setting a high bar for the back half of the year.
  • Investor sentiment remains broadly bullish, with the stock up more than 55% over the past 12 months, driven by demographic tailwinds and strong operational execution.

Why Welltower’s Q2 Report Matters

Welltower Inc., the largest publicly traded healthcare REIT by market capitalization, sits at the center of what many call the “silver economy” — the massive and growing market for senior housing and wellness services across the United States, Canada, and the United Kingdom. With a portfolio of more than 2,500 communities, WELL is a bellwether for how demographic trends translate into real estate cash flows. This Q2 report is especially important because it arrives against a backdrop of elevated investor expectations: the stock has rallied sharply, valuations are stretched by historical standards, and the company must demonstrate that its outsized same-store net operating income growth — which hit a record 16.4% in Q1 — remains sustainable heading into the second half of 2026. I also checked this using Tickeron’s AI Screener to see how WELL compares to others in the industry.

Earnings Expectations

Analysts have set a high bar for WELL’s second quarter. The Zacks Consensus Estimate for normalized FFO stands at $1.55 per share, which would mark a 21.1% improvement over the $1.28 reported in the year-ago quarter. Revenue expectations are similarly ambitious: the consensus calls for approximately $3.43 billion, implying year-over-year growth of roughly 34.5%. On a GAAP net income basis, consensus EPS estimates hover around $0.64 per share.

The company’s Seniors Housing Operating (SHO) portfolio is expected to remain the primary growth engine. In Q1, SHO same-store NOI surged 22.1%, driven by occupancy gains of roughly 370 basis points and solid revenue per occupied room (RevPOR) growth of approximately 5%. Analysts will be watching closely to see whether these occupancy and pricing trends continued in Q2, particularly given that muted new supply in senior housing has created a favorable operating environment. Interest income and other ancillary revenue streams — with consensus estimates of roughly $67 million and $30 million, respectively — will also be scrutinized for signs of diversification beyond core rental operations.

The company’s FY 2026 guidance, raised in April, calls for normalized FFO of $6.21 to $6.35 per diluted share and total portfolio same-store NOI growth of 12.25% to 16%. Q2 results will test whether the midpoint of that range remains achievable.

Market Reaction and Investor Sentiment

WELL shares have been on a remarkable run, gaining roughly 56.6% over the past 12 months and decisively outperforming both the S&P 500 and the broader real estate sector. The stock recently traded near $243, giving the company a market capitalization of approximately $170 billion. With a forward price-to-FFO multiple that some analysts consider rich, sentiment heading into this report is optimistic but carries an undercurrent of caution — the bar for a positive surprise is unusually high. From what I see in recent data, the four-quarter streak of beats adds some cushion, though the current Zacks Earnings ESP of -0.72% suggests the model is not strongly predicting another one.

Analyst coverage reflects this nuanced view. Of the 21 analysts following the stock, most rate it a Buy or Strong Buy, with a consensus price target around $237. However, Barclays initiated coverage with an Equal Weight rating and a $254 target in early July, signaling that not everyone sees compelling upside from current levels. Key risk factors heading into the print include elevated interest expenses, integration costs from recent acquisitions, and any signs of deceleration in same-store NOI growth.

Forward Outlook and Key Factors to Monitor

Beyond the headline numbers, investors should pay close attention to several forward-looking indicators embedded in WELL’s Q2 release and conference call.

First, occupancy trends in the SHO portfolio will be a major focus. The company gained approximately 370 basis points of occupancy in Q1, and any continuation — or pullback — in that trajectory will directly shape the outlook for same-store NOI growth in the second half of 2026. Communities operating at 95% or higher occupancy delivered roughly 20% NOI growth in Q1, underscoring the operating leverage embedded in the portfolio as utilization rates normalize.

Second, capital allocation activity deserves scrutiny. WELL closed $3.2 billion in investments during Q1 2026 alone, with year-to-date volumes reaching $10.5 billion. Management also signaled that an additional $7.3 billion in deals were either closed or under contract. The pace and pricing of this deployment — and whether the company continues funding it primarily through equity issuance and dispositions — will have meaningful implications for per-share growth metrics.

Third, the balance sheet remains a point of strength but also a potential sensitivity. Net debt to adjusted EBITDA stood at 2.73x as of March 31, 2026, and available liquidity totaled roughly $11.1 billion. Management has targeted a year-end leverage ratio of approximately 3.0x. Any movement above or below that range could influence how the market assesses WELL’s financial flexibility in a shifting interest rate environment.

Finally, the company’s emerging asset-light initiatives — including the external licensing of its data science platform and its $2.5 billion seniors housing fund — represent a newer dimension of the WELL story. While still modest contributors to current earnings, these fee-based revenue streams could, over time, alter the company’s growth profile and reduce its reliance on balance-sheet-intensive expansion.

Enhancing Research with Tickeron’s AI Tools

I frequently use Tickeron’s AI Screener when preparing for earnings seasons. It helps me quickly filter healthcare REITs, compare key metrics against peers, and spot stocks meeting specific technical or fundamental conditions ahead of reports like this one. The platform has become a practical part of my workflow for identifying trends in sectors with strong demographic drivers.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: WELL

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


WELL in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 05, 2026

WELL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 20 of 28 cases where WELL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WELL as a result. In 29 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 37%.

The Moving Average Convergence Divergence Histogram (MACD) for WELL turned negative on September 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 22 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.

WELL moved below its 50-day moving average on September 09, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for WELL crossed bearishly below the 50-day moving average on September 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 43%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WELL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.

The Aroon Indicator for WELL entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. WELL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.617) is normal, around the industry mean (3.199). WELL has a moderately high P/E Ratio (104.466) as compared to the industry average of (44.369). WELL's Projected Growth (PEG Ratio) (3.660) is slightly higher than the industry average of (1.649). WELL has a moderately low Dividend Yield (0.013) as compared to the industry average of (0.053). WELL's P/S Ratio (13.316) is slightly higher than the industry average of (6.013).

Industry description

The industry includes companies that publish and market books and magazines/periodicals. John Wiley & Sons, Inc., Meredith Corporation and Scholastic Corporation are some of the biggest companies in this industry. Like many other industries, publishing companies have branched out into online/digital publications (while retaining their original print business), to capture the burgeoning market in electronic media. Business could be cyclical in certain cases, since weak consumer sentiment during an economic downturn might depress sales of some magazines and books.

Market Cap

The average market capitalization across the Publishing: Books/Magazines Industry is 16.72B. The market cap for tickers in the group ranges from 113.09K to 167.86B. WELL holds the highest valuation in this group at 167.86B. The lowest valued company is DIGI at 113.09K.

High and low price notable news

The average weekly price growth across all stocks in the Publishing: Books/Magazines Industry was -3%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 0%. NHPBP experienced the highest price growth at 0%, while MPT experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Publishing: Books/Magazines Industry was 36%. For the same stocks of the Industry, the average monthly volume growth was 84% and the average quarterly volume growth was 44%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 30
P/E Growth Rating: 72
Price Growth Rating: 57
SMR Rating: 78
Profit Risk Rating: 62
Seasonality Score: 31 (-100 ... +100)
View a ticker or compare two or three
WELL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a real estate investment trust

Industry PublishingBooksMagazines

Industry
Real Estate Investment Trusts
Address
4500 Dorr Street
Phone
+1 419 247-2800
Employees
712
Web
https://www.welltower.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.